These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7373324)

  • 1. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.
    Bédard P; Parkes JD; Marsden CD
    Br Med J; 1978 Apr; 1(6118):954-6. PubMed ID: 638546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluperlapine in tardive dyskinesia and parkinsonism.
    Korsgaard S; Noring U; Gerlach J
    Psychopharmacology (Berl); 1984; 84(1):76-9. PubMed ID: 6149595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride and oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    Trans Am Neurol Assoc; 1979; 104():210-1. PubMed ID: 553412
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tiapride in tardive dyskinesia.
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J
    Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent tardive dyskinesia and parkinsonism.
    Jankovic J; Casabona J
    Clin Neuropharmacol; 1987 Dec; 10(6):511-21. PubMed ID: 2892586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose destyrosine-gamma-endorphin in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychopharmacology (Berl); 1982; 78(3):285-6. PubMed ID: 6130557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J
    Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
    J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease.
    Herring WJ; Assaid C; Budd K; Vargo R; Mazenko RS; Lines C; Ellenbogen A; Verhagen Metman L
    Clin Neuropharmacol; 2017; 40(6):255-260. PubMed ID: 29059133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders.
    Fahn S; Mayeux R
    J Neural Transm Suppl; 1980; (16):179-85. PubMed ID: 6933220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproheptadine in levodopa-induced dyskinesia in parkinsonism.
    Papavasilliou PS; Cotzias GC; McDowell FH; Rosal VL; Sheehan PJ
    Clin Pharmacol Ther; 1978 Feb; 23(2):195-8. PubMed ID: 620480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of citalopram, a specific serotonin uptake inhibitor, in tardive dyskinesia and parkinsonism.
    Korsgaard S; Noring U; Povlsen UJ; Gerlach J
    Clin Neuropharmacol; 1986; 9(1):52-7. PubMed ID: 3470139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide and haloperidol in tardive dyskinesia.
    Bateman DN; Dutta DK; McClelland HA; Rawlins MD
    Br J Psychiatry; 1979 Dec; 135():505-8. PubMed ID: 43755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.